For Adults With Active Ankylosing Spondylitis.
For Adults With Moderate to Severe Plaque Psoriasis.
For Adults With Active Psoriatic Arthritis.
You may be eligible for a $0 co-pay.* The support team at the COSENTYX® Connect Personal Support Program or your specialty pharmacy will help you coordinate this benefit.
*Limitations apply. See Program Terms and Conditions. For those commercially insured and 18 years or older. Up to a $16,000 annual cap. You will be responsible for any co-pay once limit is reached in a calendar year. This offer is not valid under Medicare, Medicaid, or any other federal or state program. Not valid for cash-paying patients. Novartis reserves the right to rescind, revoke, or amend this program without notice. Enrollment expires 12/31/16.
If you are commercially insured, but you are experiencing delays in accessing COSENTYX, you may be eligible for free medication for up to 3 months through our Initiate Program.†
†Limitations apply. Program duration covers initial 5 weekly doses (if prescribed by your doctor) and monthly doses up to program limits. Participation in the Initiate Program is not a guarantee of availability of insurance coverage or alternative financial assistance programs. Offer is not available to patients receiving Medicare, Medicaid, or any other federal or state program benefits. If during the Initiate Program, you are able to obtain insurance coverage approval for COSENTYX, you will no longer be eligible for this program. If you have not previously been treated with a biologic medication for your condition or if your insurance does not cover COSENTYX, additional free medication may be available as part of the Initiate Program. Novartis reserves the right to rescind, revoke, or amend this program without notice. Enrollment expires 12/31/16.
If you are experiencing financial hardship and have no third-party prescription drug coverage, you may be eligible to receive your Novartis medicines for free through the Novartis Patient Assistance Foundation, Inc.
We know everyone’s circumstances are different, but we’re here to help any way we can. We can help you get started by investigating your coverage. If you are experiencing financial hardship, we can direct you to the Novartis Patient Assistance Program to investigate alternative financial assistance. Please call 1-844-COSENTYX if you have any questions.
Co-pay Program Terms & Conditions:
Limitations apply. Valid only for those with commercial insurance. Up to a $16,000 annual cap. Offer not valid under Medicare, Medicaid, or any other federal or state program, for cash-paying patients, where product is not covered by patientís commercial insurance, or where plan reimburses you for the entire cost of your prescription drug. Offer is not valid where prohibited by law. Valid only in the US and Puerto Rico. This program is only valid for those patients 18 years and older. This program is not health insurance. Offer may not be combined with any other rebate, coupon, or offer. Novartis reserves the right to rescind, revoke, or amend the program without notice. Patient certifies responsibility for complying with applicable limitations, if any, of any commercial insurance and reporting receipt of program rewards, if necessary, to any commercial insurer. This offer expires on 12/31/16.
Patient Instructions: Up to a $16,000 annual cap. If you reach the annual cap of $16,000, you will be responsible for the difference. Offer expires 12/31/16. When you use this offer, you are certifying that you understand the program rules, regulations, and terms and conditions, and that you will disclose and report the use of this offer as may be required by your insurer. You are not eligible if prescriptions are paid by any federal or state program, or where prohibited by law; and you will otherwise comply with the terms and conditions above.
Your doctor will help you fill this out.
Do not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients.
COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as:
COSENTYX may lower the ability of your immune system to fight infections and may increase your risk of infections.
New cases of inflammatory bowel disease or "flare-ups" can happen with COSENTYX, and can sometimes be serious. If you have inflammatory bowel disease (ulcerative colitis or Crohn’s disease), tell your doctor if you have worsening disease symptoms during treatment with COSENTYX or develop new symptoms of stomach pain or diarrhea.
Serious allergic reactions can occur. Get emergency medical help right away if you get any of the following symptoms: feeling faint; swelling of your face, eyelids, lips, mouth, tongue, or throat; trouble breathing or throat tightness; chest tightness; or skin rash. If you have a severe allergic reaction, do not give another injection of COSENTYX.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of your medicines to show your doctor and pharmacist when you get a new medicine.
How should I use COSENTYX?
See the detailed Instructions for Use that comes with your COSENTYX for information on how to prepare and inject a dose of COSENTYX, and how to properly throw away (dispose of) used COSENTYX Sensoready® pens and prefilled syringes.
The most common side effects of COSENTYX include: cold symptoms, diarrhea, and upper respiratory infections. These are not all of the possible side effects of COSENTYX. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
COSENTYX® (secukinumab) is a prescription medicine used to treat adults with moderate to severe plaque psoriasis that involves large areas or many areas of the body, and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light, alone or with systemic therapy).